Absci (ABSI) Other Non-Current Liabilities (2020 - 2026)
Absci (ABSI) reported Other Non-Current Liabilities of $806000.0 for Q1 2026, down 52.17% on a YoY basis from $1.7 million in Q1 2025, and down 21.21% sequentially from $1.0 million in Q4 2025.
Absci (ABSI) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Other Non-Current Liabilities data on file, last reported at $806000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities fell 52.17% year-over-year to $806000.0; the trailing twelve-month figure through Mar 2026 stood at $806000.0 (down 52.17% YoY), and the FY2025 full-year result was $1.0 million, up 669.17% from the prior year.
- Other Non-Current Liabilities declined to $806000.0 in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $1.8 million in Q3 2025 to a low of $15000.0 in Q2 2024.
- A 5-year average of $560785.7 and a median of $224500.0 in 2022 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities sank 99.73% in 2022 and jumped 9780.0% in 2025, its largest moves.
- Tracing ABSI's Other Non-Current Liabilities over 5 years: stood at $35000.0 in 2022, then soared by 742.86% to $295000.0 in 2023, then tumbled by 54.92% to $133000.0 in 2024, then surged by 669.17% to $1.0 million in 2025, then fell by 21.21% to $806000.0 in 2026.
- Business Quant data shows ABSI's Other Non-Current Liabilities at $806000.0 in Q1 2026, $1.0 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 806,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.79 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 133,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 78,000.00 |
| Dec 31, 2023 | 295,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 33,000.00 |
| Jun 30, 2022 | 227,000.00 |
| Mar 31, 2022 | 222,000.00 |
| Dec 31, 2021 | 12.16 Mn |
| Sep 30, 2021 | 12.13 Mn |
| Jun 30, 2021 | 15.00 Mn |
| Dec 31, 2020 | 749,000.00 |